For instance, knockdown or overexpression of key miR‐21 target genes—such as SPRY1—in breast cancer cell lines or patient‐derived organoids could help confirm their functional roles in tumor progression and clarify the mechanistic impact of miR‐21 in breast cancer. Here, SPRY1 is linked to neoplasm.